AngioDynamics (ANGO) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Tactile Systems Technology (TCMD) has outperformed AngioDynamics (ANGO) over the past year, losing 0.4% versus a loss of 9.5%. Over five years, TCMD leads with a +23.9% price change compared with -60.3% for ANGO. Tactile Systems Technology is the larger company by market cap ($573.5 million vs $454.6 million), about 1.3 times the size.
Tactile Systems Technology converts more of its revenue into profit, with a net margin of 5.8% versus -11.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | TCMD |
|---|---|---|
| Share price | $10.81 | $25.60 |
| Market cap | $454.61M | $573.48M |
| 1-day change | +0.46% | -1.50% |
| YTD return | -15.81% | -11.72% |
| 1-year return | -9.54% | -0.39% |
| 5-year return | -60.29% | +23.85% |
| P/E ratio (TTM) | — | 24.85 |
| Forward P/E | — | 17.41 |
| EPS (TTM) | $-0.78 | $1.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $320.17M | $329.52M |
| Revenue growth (YoY) | +9.46% | +12.47% |
| Net income (latest FY) | $-36.74M | $19.09M |
| Gross margin | 54.62% | 75.91% |
| Operating margin | -12.47% | 8.89% |
| Net margin | -11.48% | 5.79% |
| 52-week high | $16.29 | $37.77 |
| 52-week low | $9.39 | $20.53 |
| Distance from 52-week high | -33.64% | -32.22% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +82.70% | +41.91% |
| Average volume | 651.16K | 248.63K |
| Shares outstanding | 42.05M | 22.40M |
| Employees | 632 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Tactile Systems Technology is more profitable, keeping 5.8 cents of every revenue dollar as net income versus -11.5 cents for AngioDynamics.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Health Care · Medical/Dental Instruments · 632 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
ANGO vs TCMD FAQ
Which is bigger, AngioDynamics or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $573.48M compared with $454.61M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or TCMD?
TCMD returned -0.39% over the past 12 months, compared with -9.54% for ANGO (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.